Kalquest Contraindications


Novell Pharma


Averroes Pharma
Full Prescribing Info
In patients with plasma potassium levels below 5 mmol/litre.
Conditions associated with hypercalcaemia (e.g. hyperparathyroidism, multiple myeloma, sarcoidosis or metastatic carcinoma).
History of hypersensitivity to polystyrene sulfonate resins.
Obstructive bowel disease.
Kalquest should not be administered orally to neonate.
Hypersensitivity to the active substance or to any of the excipients.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in